Loading…

Loading grant details…

Active HORIZON European Commission

INTERnational Cooperation of high containment research infrastructures: from Epidemic Preparedness TO Response


Funder European Commission
Recipient Organization European Research Infrastructure On Highly Pathogenic Agents
Country Belgium
Start Date Jan 01, 2024
End Date Dec 31, 2026
Duration 1,095 days
Number of Grantees 14
Roles Participant; Associated Partner; Coordinator
Data Source European Commission
Grant ID 101132215
Grant Description

Emerging infectious diseases (EID) do not respect borders. They rank as global catastrophic risks for humanity, along with climate change and biodiversity loss.

The COVID-19 pandemic showed how coordination of global research, through cooperation, and sharing of data and expertise, are crucial for efficient and effective preparedness to EIDs, and vital for a rapid response. Nevertheless, there are still major challenges limiting global cooperation among high containment laboratories (HCLs).

HCLs are critical infrastructures for the development of medical countermeasures (e.g., vaccines and therapeutics) against high consequence pathogens.

In order to fulfil its role, and given the global threat of EIDs, the European Research Infrastructure on Highly pathogenic Agents (ERINHA), together with its partners, proposes to establish and reinforce interactions with HCL research infrastructures (RI) worldwide, to strengthen pandemic preparedness and response capacities.

INTERCEPTOR (INTERnational Cooperation of high containment research infrastructures: from Epidemic Preparedness TO Response), a consortium with key HCLs from Europe and across the world, will focus on access provision to HCLs, enhancement of the human capital of HCL, including in biorisk management, critical resources sharing, harmonisation and interoperability.

The proposed actions will help ensure broader access to state-of-the-art HC facilities, while respecting the necessary biosecurity and biosafety constraints, and promote the establishment of a sustainable global network of HC RIs.

By expanding access to HC RIs, strengthening the human capital base, promoting sharing of knowledge, skills and experience, and providing opportunities for common training programmes and staff exchanges, INTERCEPTOR will reinforce the next generation of HCL researchers and facility managers, and extend the opportunities for access to HCLs, required to push the boundaries of science and innovation in the field of EIDs.

All Grantees

Philipps Universitaet Marburg; Institut National de la Sante Et de la Recherche Medicale; Medizinische Universitat Graz; National Health Laboratory Services; Instituto de Salud Carlos Iii; The University of Texas Medical Branch At Galveston; Nemzeti Nepegeszsegugyi Es Gyogyszereszeti Kozpont; European Research Infrastructure On Highly Pathogenic Agents; Department of Health; Instituto Nacional de Saude Dr. Ricardo Jorge; Eidgenossisches Departement Fur Verteidigung, Bevolkerungsschutz Und Sport; Commonwealth Scientific and Industrial Research Organisation; Istituto Nazionale Per Le Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura A Carattere Scientifico; Folkhalsomyndigheten

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant